On the other hand, studies investigating the effects of skimmianine in breast cancer remain scarce; however, evidence suggests that it may inhibit cell proliferation, induce apoptosis via caspase-3 activation, and contribute to chemoprevention by modulating the Nrf2 detoxification pathway [9,10]. Here, NFE2L2 is linked to breast cancer.